Re: [Langcom] Content in Lese

Michael Everson Tue, 01 Oct 2019 19:10:25 -0700

I forwarded this to Chuck Riley of Yale Library, who has an interest in such 
texts.


> On 2 Oct 2019, at 01:42, James Heilman <[email protected]> wrote:
> 
> Hey All
> 
> We have some content in Lese under an open license on Ebola. It is a 
> translation of this  
> https://www.nih.gov/news-events/news-releases/independent-monitoring-board-recommends-early-termination-ebola-therapeutics-trial-drc-because-favorable-results-two-four-candidates
>  
> 
> Anywere it could live in the Wikipedia world? 
> 
> -- 
> James Heilman
> MD, CCFP-EM, Wikipedian
> 
> Àngúdzù nà Óongɨ̀nɨ́ tòdhú nà àkɨsodzà ɨhdengu ba ùdhú òya dhu 
> adhì àtona  ladze ladze nà òbénɨ ayi àsɨ̀lebhɨ òndè nà Èbhòlà 
> bhayi iìwé RDC  adhì bho, àkisubà londɨ nà ɨlèmba ayi àmʉdó nà 
> èdzo adhì bho bà édzɨ́tò adhì kèke bànɨ́.
> 
>  
> Oòngó òyɨ mʉ̀bhʉ́ bha 12 ánɨ̀ uùlénɨ̀ òyɨ bha 09 2019, àkokpè 
> àmʉ̀dó nà òndè ánɨ̀ adhi àbhé 681 ɨlèbhɨ́ dhu bhàbè bànɨ́ 
> àmʉ̀dó kadza 725. Òndè nà Èbòlà lùsí badhì nà édzɨ́tò adhì 
> kèke bà akòkpè àmʉ̀dó nà òndè ánɨ̀ adhì àbhé:  Ìbhógú na 
> Katwa bà, Butembo bà àba Mangina bà. Ʉmbá lùsí bà nà ledhì 
> ayɨ̀kasʉ́ nà sòkú nà kàlʉ̀ ayi nà àsɨ̀tagà « Institut national de 
> recherche biomédicale » (INRB), àba àngúdzù ngbówú nà ʉ̀mbá lùsí 
> bhayi nà ìbhórú ànda nà RDC ayi, àba ùdhu òya nà ʉ̀mbá lùsí 
> bhadhì dhèkú èdzɨnà, àtagà ɨ̀dhé : Oòngɨ̀nɨ́ nà ùdhú òya dhú 
> àyi nà ìbhógú nbgówú ɨ̀nɨ́ kèke ayi, tòdhó lʉ́bhó ánɨ̀ (Alliance 
> pour action medicale international, (ALIMA) àba, International Medical Corps 
> (IMC), àba óbhó ʉ̀mbá lùsí tòdhú nà áwé èmbi ayi, tòdhó lʉ́bhó 
> ánɨ̀ Médecin sans frontière, MSF), ùdhu òya ndɨ̀kà nà àsɨ̀taga : Edhi 
> àmba nɨ òdhò ɨ̀dhó dhu,(ensemble pour sauver la vie) kadza lebhɨ lebhɨ 
> nà àkɨsɨtayi àba àkɨsendà ɨ́ngámá ayi, ámʉ̀dó nà èlu ènda ndɨ́le 
> ánɨ̀ àkɨsodzà kàlʉ̀ adhì, ɨ̀dhe àtagà (ZMapp, àba remdesivir, àba 
> mAb114 àba RGEN-EB3), ɨ̀dhe àkɨbhà àmʉ̀dó nà àkɨsubà òndè nà 
> Èbhòlà bhayi adhì ʉ̀mbá lùsí dhu. Táyí táyí ndɨ̀le kúkànɨ́ òyɨ 
> mʉ̀dhʉ́ bha 20 tìmbá bha àmbʉ̀dzɨ́ ídzù èdhi ánɨ̀ 2018 ìbhógú 
> ngbúwú nà Congo kèke bà (RDC) oòto adzɨbà bhé ayiwè òbénɨ òndè 
> nà Ebola bha mʉ̀sʉ̀fʉ̀ àmʉ̀dó ibhèli ìbhógú ànda légò nà Nord-Kivu 
> àba Ituri kèke bà ayi.
> 
>  
> Lebhɨ lebhɨ nà leyi àngúdzù nà àsɨ̀tʉnvʉ èlú ɨ̀nɨ́ nà àkisubà 
> táyí táyí kèke bà ayi àdhì àba tʉ̀nvʉ tòdhú ɨ̀nɨ́ nà àsùyà 
> ùdhú àmʉ̀dó dhèkú èmbi bà adhì nà àsʉ̀dza aàdúnɨ̀ òyɨ édhí 
> édhi èlu ndɨ̀le lòndɨ dhú adhì ɨ̀nɨ́ àwʉ̀dza oòto. Londɨ nà ɨ́ngamá 
> ùdhú kàkɨ dhú ayi èdɨ dhú adzɨtayí ɨ̀nɨ́ nà ùdhú ndɨ̀le àkɨsukà 
> adhì nɨ́. Lebhɨ lebhɨ nà òyɨ mʉ̀bhʉ́ bha 09 tìmbá bha gbàndà ánɨ̀ 
> 2019 ánɨ̀ ayi nɨ́ lɨvʉ, DSMB kɨtòna àkamòbhò táyí táyí àba 
> àkamòkpè bhàbè òndè tòdhú nà àselè lɨvʉ adhì REGN-EB3 ɨ̀ngó dhu 
> àba mAb114 áwé nà àsɨkasɨlòndɨ̀ táyí táyí kɨsalenɨ̀ ayi. Lonndɨ nà 
> leyi kadza lèdzɨ́nɨ́ táyí táyí ná REGN-EB3 kɨsoyà ayi kɨsɨlafù 
> àmʉ̀dó nà àsɨ̀londɨ̀ àkòbhò táyí táyí adhì ʉ̀webhʉ ɨ́ngámá ayi 
> nɨ́bà. Àkɨsubà àmʉ̀dó nà 499 adhì nà àkɨselè táyí táyí bà 
> adhì bho bà adhì àkɨtàdhʉ́ àsíyènà àmʉ̀dó nà àkɨsubà REGN-EB3 
> àba mAb114 adhì àkadza sásè nà Oòdhò bhayi ánɨ̀ kàkʉ ɨlàdhí 
> àmʉ̀dó dhèkú bhówá nà àkɨselè édzó ledhì kèke ádhi.
> 
>  
> Táyí táyí tòdhú nà itù àdhì, àba àsedɨ mòbhì ɨ̀nɨ́ adhì 
> àkɨtalu  londɨ nà ùdhú kàkɨ ɨ́ngámá dhu leyi, àba ayɨ̀kásʉ́ ɨ̀nɨ́ 
> nà d’ ATC àdhi ɨtòsónɨbà dzù adhì nɨ́ àkɨtènɨ̀ òbhénɨ. Aba iìwé 
> dzù nɨ́ òndè tòdhú nà mòbhɨ̀ ɨ̀dhe bhayi kɨ́sɨ́ngendanɨ̀ adhì, òndè 
> tòdhú nà lɨvʉ adhì nà REGN-EB3 àba  mAb114  adhì, àba òndè tòdhú 
> ɨ̀nɨ́ nà àkɨsoga màlɨ́ bhadzɨ adhì òyɨ àmbʉ̀dzɨ́ àkubà sásè nà 
> òdhò bhayi mòkpè nà ʉ̀mbá lùsí tòdhú nà ɨ̀dhe bha kàlʉ̀ ayi bho 
> bà, dò ɨ̀dhe kùbà REGN-EB3 àba mAb114.   
> 
>  
> Tàyɨ táyí táyí nà áwé mba ayi mʉ̀tadhʉ̀ àsíyè bhètì áwé èdhi 
> èlú ɨ̀nɨ́ nà àkɨsubà adhì nà àsɨtòdhù (áwé nà tìmbá bha ɨ̀sɨ́ 
> bhayi mba bà sókó ùkà ùkà nà tìmbá bha àmbʉ̀dzɨ́ bhayi nà 2019, 
> DSMB àba táyí táyí àbayìdhu ɨ̀nɨ́ kɨlèbhɨ àsíyènà londɨ nà itù 
> adhì nà àkisubà adhì nà kɨsodzà àdhi kadza kàkʉ̀ londɨ lùsí bhayi 
> ùdhú kàkɨ ɨngámá dhu àba àkisubà táyí táyí kè bà ayi nɨ́ kásʉ́ 
> èdɨ dhú.Londɨ àsubà táyí táyí kèke bà ayi nà kɨsodzà kòpèle ayi 
> àwʉ̀kpe dò àyibhà bhúkù ɨ̀nɨ́ nà àkɨsokpè ʉ̀mbá lùsí dzù adhì 
> kèke, mʉ̀sɨ̀letè tàyalɨ̀ àbha.
> 
>  
> Táyí táyí nà ndɨ̀le àkɨlèbhɨ àba l’INRB kedɨ̀ ògákékí kásʉ́ 
> ndɨ̀le kàkɨ dhú, àba sòkú ngbówú nà àsɨ̀tagá : Institut national 
> des maladies allergiques et infectieuses (NIAID) adhì sòkú ngbówú ɨ̀nɨ́ 
> nà ʉ̀mbá lùsí dzù adhì nà Etats-Unis adhì ánɨ̀. Àsʉ̀ngɨ́nɨ̀ ùdhú 
> nà èdhi ayi òya dhú adhì nà ìbhógú ànda ngbówú ɨ̀nɨ́ kèke adhì 
> nà àsʉ̀tò ùdhú ʉ̀mbá lùsí bhayi àhdi nà àsɨ̀taga OMS leyi koyà 
> ɨ́lé, àba ùdhu òya ngbówú  ɨ̀nɨ́ nà èdzɨto adhì nà lònzɨ̀ làga 
> tòdhú ɨ̀nɨ́ bhadhì nà àsɨ̀tagà (MappBio, Gilead, Regeneron àba 
> Ridgeback Biotherapeutics) ledhì kedɨ̀ ògákekí ɨ̀le dhú.  
> 
> NIAID, INRB àba OMS àalì lèdzɨ́nɨ́ kàkʉ̀ àmʉ̀dó nà ɨ́yá nà àsùyà 
> kásʉ́ èlú awe nà ɨ́kókʉ́ ayi kèke bà táyí táyí nà layi dhù 
> ádhi, àba àmʉ̀dó nà DSMB kèke adhì, àba òndè tòdhú ɨ̀nɨ́ nà 
> àkɨsoyà kásʉ́ táyí táyí nà layi kèke adhì awì nà ɨ̀dhe bhadhì 
> ánɨ̀ bhàyɨ̀. Táyí táyí kéwʉ́ ngbówú nà lèdzɨ leyi nɨ́bà àba 
> òbénɨ̀ ùdhu òya nà àmʉ̀ bhayi nɨ́bà àmʉ̀ katè úubà àdzɨdzɨ bà 
> bhé àmʉ̀ katè òbénɨ àba bhàdumbì ndéngé nà lonzɨ eèdɨ bhayi àba 
> ɨɨ̀sɨ́ ɨ̀dhe òndè nà Èbhòlà bhayi ánɨ̀ ɨlabhʉ́nʉ̀ bhayi kèke kásʉ́ 
> nà.
> 
>  
> ÀDHÈ :
> 
> Tòdhó àsɨ̀lodhɨ̀ adhì nà : Anthony S. Fauci, Dìlèkìtélè nà NIAID : 
> Dìlèkìtélè ngbówú nà INRB bhayi, ayɨ̀tàdhʉ ngbówú nà Jean-Jacques 
> Muyembe-Tamfum, MD, Ph.D ; àba Michael J. Ryan MD, Dìlèkìtélè adzòyà 
> plògàlámè bhayi nà OMS bhayi, bhètì òbénɨ ayi tóná nà ʉ̀mbá 
> lùsí dhu.
> 
>  
> Aàdúnɨ̀
> 
> Mʉ̀sedɨ̀ plògàlámè nà ɨ́tòdhónɨ̀ bhayi ayi, àdhu
> 
> NIAID Àyɨ́ ngbówú nà àsɨtodho àba àsʉ̀ngɨ́nɨ̀ ayɨ̀kásʉ́ ɨ̀nɨ́ nà 
> gùvèlènèma kèke adhì ánɨ̀ ayi:  (Dr. Fauci)
> 
> (301) 402-1663
> 
> [email protected]
> Mʉ̀sedɨ̀ plògàlámè nà ɨ́tòdhónɨ̀ bhayi ayi, àdhu
> 
> Dr. Sabue Mulangu (Dr. Muyembe)
> 
> +243 826 792 353
> 
> [email protected]
> Mʉ̀sedɨ̀ plògàlámè nà ɨ́tòdhónɨ̀ bhayi ayi, àdhu
> 
> Nyka Alexander (Dr. Ryan)
> 
> +4179 634 0295
> 
> [email protected]
>  
> Mòkpè nà layi àkengbe áwé nà lɨvʉ ayi ánɨ̀ òyɨ mʉ̀bhʉ́ bha 12 
> tìmbá bha gbàndà ánɨ̀ 2019 bha.
>  
> US National Institute of Health, August 12, 2019.  Distributed with 
> permission.
> 
> Translated into Lese by Corneille Melimunvu for Athinkra, LLC.
> 
> _______________________________________________
> Langcom mailing list
> [email protected]
> https://lists.wikimedia.org/mailman/listinfo/langcom


_______________________________________________
Langcom mailing list
[email protected]
https://lists.wikimedia.org/mailman/listinfo/langcom

Re: [Langcom] Content in Lese

Reply via email to